CDC advisers to review heart inflammation link to mRNA COVID jabs
Al Jazeera
The United States Centers for Disease Control and Prevention has identified a total of 216 cases of heart inflammation after the first dose of an mRNA shot, and another 573 cases after the second dose.
U.S. public health advisers will meet to discuss a potential link between Covid-19 shots that use messenger RNA technology and heart inflammation after hundreds of vaccinated people experienced a condition called myocarditis. The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will gather on June 18 to discuss an increase in reported cases of the condition, particularly among adolescents and young adults. Covid vaccines made by Moderna Inc. and partners Pfizer Inc. and BioNTech SE’s use mRNA technology. Since April, the CDC has seen a spike in reports of myocarditis along with pericarditis, an inflammation of the membrane around the heart. The cases, while rare, have occurred mostly in male teens and young adults.
Small islands and least-developed nations say their climate finance interests were ignored.
Global lender says it will release about $333m to crisis-hit nation as signs of economic recovery emerge.
At least four people have been killed in the attack on the Basta neighbourhood, according to the Health Ministry.
A series of unexplained incidents causing damage to pipelines and cables in the Baltic Sea has occurred in the past two years. Could this be a new form of underwater warfare?
The hedge fund manager will be responsible for implementing president-elect’s pledges to cut taxes and raise tariffs.
Cola Gaza offers its drinkers an ‘apartheid-free’ alternative as they boycott big-name brands.
These were the key developments on the 1,003rd day of the Russia-Ukraine war.
Defectors from Myanmar’s military and police are learning skills that could put them on a new path after years of war.
World Health Organization says 226 health workers, patients killed in Lebanon since start of Israel’s war on Hezbollah.
